Results for tag: "Tetravax"

The Tetravax market is a segment of the larger Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Tetravax vaccines are specifically designed to protect against four diseases: diphtheria, tetanus, pertussis, and polio. These vaccines are typically administered in a single dose, and are often given to children as part of a routine immunization schedule. Tetravax vaccines are widely used in many countries, and are considered to be an important tool in the fight against infectious diseases. The Tetravax market is highly competitive, with many companies offering their own versions of the vaccine. Some of the major players in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more